Sindhoori Surgicals & Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 15-11-2024
- Paid Up Capital ₹ 2.00 M
as on 15-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 15-11-2024
- Revenue %
(FY 2023)
- Profit 4048.94%
(FY 2023)
- Ebitda 4127.09%
(FY 2023)
- Net Worth 54067.13%
(FY 2023)
- Total Assets 81.74%
(FY 2023)
About Sindhoori Surgicals & Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹1.00 Cr.
Nikhileswar Gari, Susmitha Gopireddy, Aruna Nallaiahgari, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100TG2020PTC140879
- Company No.
140879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sindhoori Surgicals & Pharma Private Limited offer?
Sindhoori Surgicals & Pharma Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Rehabilitation Equipment, Wheel Chairs, Crutches and Walker, Walking Aids, Exercise Bikes & Fitness Equipments, Ellipticals, Crutches, Movable Walker, Rehab Immobilizers, Furniture Fittings & Hardware.
Who are the key members and board of directors at Sindhoori Surgicals & Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhileswar Gari  | Director | 25-Nov-2022 | Current |
| Susmitha Gopireddy | Director | 16-Jun-2020 | Current |
| Aruna Nallaiahgari | Director | 16-Jun-2020 | Current |
| Parvathi Gopireddy | Director | 25-Nov-2022 | Current |
Financial Performance of Sindhoori Surgicals & Pharma.
Sindhoori Surgicals & Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 4048.94% increase in profit. The company's net worth Soared by an impressive increase of 54067.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sindhoori Surgicals & Pharma?
Unlock access to Sindhoori Surgicals & Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Innovate Medpharma Private LimitedActive 2 years 3 monthsNikhileswar Gari and Susmitha Gopireddy are mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
| 20 Jul 2022 | Hdfc Bank Limited | ₹8.50 M | Open |
How Many Employees Work at Sindhoori Surgicals & Pharma?
Sindhoori Surgicals & Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sindhoori Surgicals & Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sindhoori Surgicals & Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.